Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction: A Prespecified Secondary Analysis of the REVIVED-BCIS2 Trial

IMPORTANCE: In the Revascularization for Ischemic Ventricular Dysfunction (REVIVED-BCIS2) trial, percutaneous coronary intervention (PCI) did not improve outcomes for patients with ischemic left ventricular dysfunction. Whether myocardial viability testing had prognostic utility for these patients o...

Descripción completa

Detalles Bibliográficos
Autores principales: Perera, Divaka, Ryan, Matthew, Morgan, Holly P., Greenwood, John P., Petrie, Mark C., Dodd, Matthew, Weerackody, Roshan, O’Kane, Peter D., Masci, Pier Giorgio, Nazir, Muhummad Sohaib, Papachristidis, Alexandros, Chahal, Navtej, Khattar, Rajdeep, Ezad, Saad M., Kapetanakis, Stam, Dixon, Lana J., De Silva, Kalpa, McDiarmid, Adam K., Marber, Michael S., McDonagh, Theresa, McCann, Gerry P., Clayton, Tim C., Senior, Roxy, Chiribiri, Amedeo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600721/
https://www.ncbi.nlm.nih.gov/pubmed/37878295
http://dx.doi.org/10.1001/jamacardio.2023.3803

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600721/
https://www.ncbi.nlm.nih.gov/pubmed/37878295
http://dx.doi.org/10.1001/jamacardio.2023.3803

Ejemplares similares